Evidence map›Paper›PMID 17103241›Full record

ArticleTransgenic research2007

Establishment and characterization of CAG/EGFP transgenic rabbit line.

Ri-ichi Takahashi, Takashi Kuramochi, Kazuki Aoyagi, Shu Hashimoto, Ichiro Miyoshi, Noriyuki Kasai, Yoji Hakamata, Eiji Kobayashi, Masatsugu Ueda

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ri-ichi TakahashiThe YS Institute Inc., 1198-4 Iwazo, Utsunomiya, Tochigi, Japan. ystg@ystg.co.jp
Takashi Kuramochi
Kazuki Aoyagi
Shu Hashimoto
Ichiro Miyoshi
Noriyuki Kasai
Yoji Hakamata
Eiji Kobayashi
Masatsugu Ueda
Utsunomiya University · JPJichi Medical University · JPNagoya City University · JPNippon Veterinary and Life Science University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell marking is a very important procedure for identifying donor cells after cell and/or organ transplantation in vivo. Transgenic animals expressing marker proteins such as enhanced green fluorescent protein (EGFP) in their tissues are a powerful tool for research in fields of tissue engineering and regenerative medicine. The purpose of this study was to establish transgenic rabbit lines that ubiquitously express EGFP under the control of the cytomegalovirus immediate early enhancer/beta-actin promoter (CAG) to provide a fluorescent transgenic animal as a bioresource. We microinjected the EGFP expression vector into 945 rabbit eggs and 4 independent transgenic candidate pups were obtained. Two of them died before sexual maturation and one was infertile. One transgenic male candidate founder rabbit was obtained and could be bred by artificial insemination. The rabbit transmitted the transgene in a Mendelian manner. Using fluorescence in situ hybridization analysis, we detected the transgene at 7q11 on chromosome 7 as a large centromeric region in two F1 offspring (one female and one male). Eventually, one transgenic line was established. Ubiquitous EGFP fluorescence was confirmed in all examined organs. There were no gender-related differences in fluorescence. The established CAG/EGFP transgenic rabbit will be an important bioresource and a useful tool for various studies in tissue engineering and regenerative medicine.

Indexed as

AnimalsAnimals, Genetically ModifiedBreedingFemaleFluorescenceGene ExpressionGenetic EngineeringGenetic VectorsGreen Fluorescent ProteinsIn Situ Hybridization, FluorescenceMaleRabbitsRecombinant ProteinsTissue Distributionenhanced green fluorescent proteinGreen Fluorescent ProteinsRecombinant Proteins

Identifiers

PMID17103241
OpenAlexW1968101167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.